Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Jul 2;17(4):10.4088/PCC.15m01782.
doi: 10.4088/PCC.15m01782. eCollection 2015.

Selective Immunoglobulin M Deficiency Among Clozapine-Treated Patients: A Nested Case-Control Study

Roberto Lozano  1 , Reyes Marin  1 , Maria-Jesus Santacruz  1 , Asunción Pascual  1
Affiliations

Selective Immunoglobulin M Deficiency Among Clozapine-Treated Patients: A Nested Case-Control Study

Roberto Lozano et al. Prim Care Companion CNS Disord. .

Abstract

Objective: To analyze the presence of selective immunoglobulin M immunodeficiency (SIgMD) among long-term clozapine-treated outpatients in a nested case-control study.

Method: We investigated 33 patients who took clozapine and found 6 patients with SIgMD. These patients were compared with 67 patients not taking clozapine, of whom 2 had SIgMD. Of these 6 and 2 patients, we made a group of 8 case-patients with SIgMD. This group was compared with 92 (27 + 65) patients without SIgMD matched to cases on age, sex, weight, mental health unit, diagnosis, and psychiatric medication. In both groups there were patients who had taken clozapine: 6 of 8 in the SIgMD group (75%) and 27 of 92 in the non-SIgMD group (29%). SIgMD was defined by mean IgM values ≤ 30 mg/dL. IgM measurements were performed every 6 months, and the data were averaged for each subject. The study was conducted from January 2009 to December 2013.

Results: We found a statistical association between clozapine use and the presence of SIgMD (OR = 7.2222; 95% CI, 1.3704-38.0623; Z = 2.332; P = .0197).

Conclusions: Due to the high incidence of SIgMD observed in schizophrenic patients treated with clozapine, clinicians should pay particular attention to not only granulocyte counts but also patterns of IgM decline to prevent drug iatrogenesis.

PubMed Disclaimer

References

    1. Maes M, Meltzer HY, Bosmans E. Immune-inflammatory markers in schizophrenia: comparison to normal controls and effects of clozapine. Acta Psychiatr Scand. 1994;89(5):346–351. - PubMed
    1. Hinze-Selch D, Becker EW, Stein GM, et al. Effects of clozapine on in vitro immune parameters: a longitudinal study in clozapine-treated schizophrenic patients. Neuropsychopharmacology. 1998;19(2):114–122. - PubMed
    1. Cassidy JT, Nordby GL. Human serum immunoglobulin concentrations: prevalence of immunoglobulin deficiencies. J Allergy Clin Immunol. 1975;55(1):35–48. - PubMed
    1. Goldstein MF, Goldstein AL, Dunsky EH, et al. Selective IgM immunodeficiency: retrospective analysis of 36 adult patients with review of the literature. Ann Allergy Asthma Immunol. 2006;97(6):717–730. - PubMed
    1. Al-Amin MM, Nasir Uddin MM, Mahmud Reza H. Effects of antipsychotics on the inflammatory response system of patients with schizophrenia in peripheral blood mononuclear cell cultures. Clin Psychopharmacol Neurosci. 2013;11(3):144–151. - PMC - PubMed